Large employers fear vaccine mandates will chase away workers. But 'real world data tells a different story.'
As COVID-19 vaccine mandates roll out across federal agencies and among many private businesses, companies that fall under the Biden administration's vaccine-or-test requirement are worried about employees quitting, a new poll has found.
President Biden directed the Labor Department to develop a rule that companies with 100+ employees must require proof of vaccination or weekly negative test results. It hasn't taken effect yet, but many of those employers told the Society for Human Resource Management they're worried it will lead to lots of resignations, reports The Hill.
"Nearly 9 in 10 large employers believe some of their workers will quit their jobs over the Biden administration's coronavirus vaccine-or-test mandate," writes The Hill. Some are worried about general workplace disruption, while others are concerned about the cost of acquiring rapid COVID-19 tests. Two-thirds of those surveyed said they could not afford to pay for weekly testing.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Fears that employees will quit en masse or move to smaller companies not affected by the rule are understandable, but other data doesn't point to the worries being warranted. As The Hill writes, "real world data tells a different story," pointing to United Airlines announcing layoffs of 230 employees who didn't comply with vaccine requirements — 0.3 percent of its workforce. Similarly, 58 percent of those surveyed in a September Morning Consult poll supported the Biden administration's vaccine mandate for large companies.
The Society for Human Resource Management surveyed 1,289 of its members online between Sept. 27-30. Read more at The Hill.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Summer Meza has worked at The Week since 2018, serving as a staff writer, a news writer and currently the deputy editor. As a proud news generalist, she edits everything from political punditry and science news to personal finance advice and film reviews. Summer has previously written for Newsweek and the Seattle Post-Intelligencer, covering national politics, transportation and the cannabis industry.
-
Metaverse: Zuckerberg quits his virtual obsessionFeature The tech mogul’s vision for virtual worlds inhabited by millions of users was clearly a flop
-
Frank Gehry: the architect who made buildings flow like waterFeature The revered building master died at the age of 96
-
Is MAGA melting down?Today's Big Question Candace Owens, Tucker Carlson, Laura Loomer and more are feuding
-
A fentanyl vaccine may be on the horizonUnder the radar Taking a serious jab at the opioid epidemic
-
Health: Will Kennedy dismantle U.S. immunization policy?Feature ‘America’s vaccine playbook is being rewritten by people who don’t believe in them’
-
How dangerous is the ‘K’ strain super-flu?The Explainer Surge in cases of new variant H3N2 flu in UK and around the world
-
Vaccine critic quietly named CDC’s No. 2 officialSpeed Read Dr. Ralph Abraham joins another prominent vaccine critic, HHS Secretary Robert F. Kennedy Jr.
-
This flu season could be worse than usualIn the spotlight A new subvariant is infecting several countries
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
